Drug · DIN 02013231
LITHANE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 23, 2022; first marketed December 31, 1993.
- Drug Identification Number (DIN)
- 02013231
- Company (DIN owner)
- Searchlight Pharma Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Lithium N05AN01
- Class
- Human
- Record last updated
- January 7, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LITHIUM CARBONATE | 150 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 22, 2022: NOC 29073New Drug Submission (NDS) · Administrative: Change in Product Ownership
- July 12, 2005: NOC 7237New Drug Submission (NDS) · Manufacturer name change
Other DINs named LITHANE
- DIN 00406775 · Marketed